Rehabilitation and Educational Services, Inc. (RESI), a 501(c)(3) affiliate of RCPA, has been awarded a $25,000 grant from Staunton Farm Foundation (SFF) for a project that will help provide a better understanding of clients’ experience in substance use treatment. By exploring the treatment experience, the project, “Client Experience in Substance Use Treatment: A Statewide Inventory,” will provide a powerful tool for evidence-based advocacy. Using one-on-one interviews and journey mapping with clients currently in treatment for substance use, the RESI team will capture, for example, clients’ experiences with counselor rapport, facility safety, treatment protocols, regulatory requirements, and care coordination. Although SFF’s work to enhance behavioral health treatment and support is focused on the 10-county southwest region of Pennsylvania, RESI intends to conduct this project across the state. As such, RESI is continuing to seek additional funding partners statewide. RESI’s mission is to improve the delivery of services to vulnerable and underserved individuals through research and education of providers, policymakers, lawmakers, the public, and the individuals receiving services through these systems. RESI will achieve its mission predominantly through research-based initiatives, publishing and disseminating its findings to key stakeholders to improve service delivery in multiple ways and at multiple levels. “We are extremely grateful to Staunton Farm Foundation for this funding and their confidence in RESI to execute this project,” said RESI Executive Director Jason Snyder. “Using data on treatment lengths of stay, early discharges, readmissions, and post-discharge follow-up, for example, is inadequate in designing a person-centered system; the client voice and experience must be heard. “For decades, Staunton Farm Foundation has been a highly respected organization whose dedication to improving the lives of people who live with mental illness or substance use disorders has had a profound impact on southwestern Pennsylvania. It is a privilege to partner with them on this effort to raise up the very individuals they have long served.”
ANCOR has developed a shorter version of the 2026 National Survey and also extended the survey deadline to Tuesday, October 20, 2026!
GLP-1s may be popular for weight loss, but evidence is mounting that they are effective at treating substance use disorder (SUD) and other addictions as well.